CME
Questions and Conundrums: What Is the Future of ADCs in HR+/HER2-Low MBC?
July 17, 2023
Host: Erica L. Mayer, MD, MPH
Host: Sarah Sammons, MD
This program explores new evidence that challenges the binary paradigm of HER2+ versus HER2- disease. Evidence is now available that specific antibody-drug conjugates (ADCs) have demonstr
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!